SE9904377D0 - Pharmaceutical combinations - Google Patents
Pharmaceutical combinationsInfo
- Publication number
- SE9904377D0 SE9904377D0 SE9904377A SE9904377A SE9904377D0 SE 9904377 D0 SE9904377 D0 SE 9904377D0 SE 9904377 A SE9904377 A SE 9904377A SE 9904377 A SE9904377 A SE 9904377A SE 9904377 D0 SE9904377 D0 SE 9904377D0
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical combinations
- combinations
- present
- pharmaceutical
- provides novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (37)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904377A SE9904377D0 (sv) | 1999-12-01 | 1999-12-01 | Pharmaceutical combinations |
ARP000106143A AR033658A1 (es) | 1999-12-01 | 2000-11-21 | Kit de componentes, metodo para el tratamiento de la trombosis,uso de un antagonista del receptor p2t en la elaboracion de un kit de componentes para el tratamiento de la trombosis, formulacion farmaceutica, uso de la formulacion farmaceutica en la elaboracion de un medicamento para el tratamiento d |
KR1020027007026A KR100785953B1 (ko) | 1999-12-01 | 2000-11-29 | 약학 조합제제 |
CA2391161A CA2391161C (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations comprising a p2t receptor antagonist and an anti-thrombotic agent |
BR0016043-1A BR0016043A (pt) | 1999-12-01 | 2000-11-29 | Kit de partes, método para tratar trombose, uso de um antagonista de receptor p2t ou de um seu derivado farmaceuticamente aceitável, formulação farmacêutica, uso desta, processo para prepará-la, e, uso de um composto de fórmula ou de um seu derivado farmaceuticamente aceitável |
DE60029340T DE60029340T2 (de) | 1999-12-01 | 2000-11-29 | Pharmazeutische zusammenstellungen enthaltend einen p2t rezeptor antagonist und melagatran |
EP00982033A EP1237559B1 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations comprising a p2t receptor antagonist and melagatran |
RU2002117296/15A RU2242232C2 (ru) | 1999-12-01 | 2000-11-29 | Фармацевтические комбинации |
AU19109/01A AU781691B2 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations |
SI200030885T SI1237559T1 (sl) | 1999-12-01 | 2000-11-29 | Farmacevtska kombinacija vsebujoca p2t receptor antagonist in melagatran |
PCT/SE2000/002378 WO2001039781A1 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations |
NZ518904A NZ518904A (en) | 1999-12-01 | 2000-11-29 | A pharmaceutical composition comprising a P2T receptor antagonist, or a pharmaceutically acceptable salt thereof, and an anti-thrombotic agent, and the use of the combination in the treatment and prevention of thrombosis |
AT00982033T ATE332698T1 (de) | 1999-12-01 | 2000-11-29 | Pharmazeutische zusammenstellungen enthaltend einen p2t rezeptor antagonist und melagatran |
CN00816374A CN1402639A (zh) | 1999-12-01 | 2000-11-29 | 药用组合物 |
IL14949500A IL149495A0 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical formulations comprising p2t receptor antagonist and anti-thrombotic agent and use thereof in therapy |
EP06075955A EP1719526A3 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations comprising a P2T receptor antagonist and another anti-thrombotic agent |
PT00982033T PT1237559E (pt) | 1999-12-01 | 2000-11-29 | Combinacoes farmaceuticas compreendendo um antagonista do receptor p2t e megalatrano |
MYPI20005578A MY128896A (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations |
NZ530058A NZ530058A (en) | 1999-12-01 | 2000-11-29 | A pharmaceutical combination comprising a P2T receptor antagonist, or a pharmaceutically acceptable salt thereof, and an anti-thrombotic agent, and the use of the combination in the treatment and prevention of thrombosis |
MXPA02004871A MXPA02004871A (es) | 1999-12-01 | 2000-11-29 | Combinaciones farmaceuticas. |
JP2001541513A JP2003515565A (ja) | 1999-12-01 | 2000-11-29 | 薬剤の組合せ |
ES00982033T ES2267591T3 (es) | 1999-12-01 | 2000-11-29 | Combinaciones farmaceuticas que comprenden un antagonista del receptor p2t y melagatran. |
DK00982033T DK1237559T3 (da) | 1999-12-01 | 2000-11-29 | Farmaceutiske kombinationer som omfatter en P2T-receptor-antagonist og melagatran |
CO00091389A CO5271717A1 (es) | 1999-12-01 | 2000-11-29 | Combinaciones farmaceuticas |
CZ20021887A CZ300925B6 (cs) | 1999-12-01 | 2000-11-29 | Kit ze soucástí pro antitrombotickou terapii, antagonista receptoru P2T, farmaceutický prostredek a lécivo pro lécení trombózy |
HU0203585A HU230890B1 (hu) | 1999-12-01 | 2000-11-29 | Egy P2T receptor antagonistát és melagatrant tartalmazó gyógyszerkombinációk |
SK750-2002A SK288707B6 (sk) | 1999-12-01 | 2000-11-29 | Farmaceutické kombinácie obsahujúce antagonistu P2T receptora a ďalšie antitrombotické činidlá, spôsob ich prípravy a ich použitie na liečenie a prevenciu trombózy |
PL355841A PL203430B1 (pl) | 1999-12-01 | 2000-11-29 | Zestaw leczniczy zawieraj acy antagonist e receptora P2T, zastosowanie antagonisty receptora P2T, preparat farmaceutyczny zawieraj acy antagonist e receptora P2T |
EEP200200271A EE05127B1 (et) | 1999-12-01 | 2000-11-29 | Osadest koosnev komplekt ja ravimpreparaat, mis sisaldavad P2T-retseptori antagonisti v?i selle farmatseutiliselt vastuv?etavat derivaati ja tromboosivastast ainet, ning nende kasutamine meditsiinis |
US10/148,526 US20030032618A1 (en) | 1999-12-01 | 2000-11-29 | Pharmaceutical combinations |
TW089125873A TWI251491B (en) | 1999-12-01 | 2000-12-05 | Pharmaceutical combinations |
ZA200203707A ZA200203707B (en) | 1999-12-01 | 2002-05-09 | Pharmaceutical combinations. |
IS6398A IS2841B (is) | 1999-12-01 | 2002-05-27 | Samstæða hluta og lyfjasamsetningar |
NO20022606A NO331215B1 (no) | 1999-12-01 | 2002-05-31 | Kit av deler og farmasoytiske formuleringer |
HK03100127A HK1047893A1 (en) | 1999-12-01 | 2003-01-06 | Pharmaceutical combinations comprising a p2t receptor antagonist and melagatran |
US11/441,278 US20060270607A1 (en) | 1999-12-01 | 2006-05-25 | Pharmaceutical combinations |
CY20061101267T CY1105211T1 (el) | 1999-12-01 | 2006-09-05 | Φαρμακευτικοι συνδυασμοι που πepιλαμβανουν εναν ανταγωνιστη του υποδοχεα p2τ και μελαγατρανη |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904377A SE9904377D0 (sv) | 1999-12-01 | 1999-12-01 | Pharmaceutical combinations |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9904377D0 true SE9904377D0 (sv) | 1999-12-01 |
Family
ID=20417947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9904377A SE9904377D0 (sv) | 1999-12-01 | 1999-12-01 | Pharmaceutical combinations |
Country Status (33)
Country | Link |
---|---|
US (2) | US20030032618A1 (es) |
EP (2) | EP1719526A3 (es) |
JP (1) | JP2003515565A (es) |
KR (1) | KR100785953B1 (es) |
CN (1) | CN1402639A (es) |
AR (1) | AR033658A1 (es) |
AT (1) | ATE332698T1 (es) |
AU (1) | AU781691B2 (es) |
BR (1) | BR0016043A (es) |
CA (1) | CA2391161C (es) |
CO (1) | CO5271717A1 (es) |
CY (1) | CY1105211T1 (es) |
CZ (1) | CZ300925B6 (es) |
DE (1) | DE60029340T2 (es) |
DK (1) | DK1237559T3 (es) |
EE (1) | EE05127B1 (es) |
ES (1) | ES2267591T3 (es) |
HK (1) | HK1047893A1 (es) |
HU (1) | HU230890B1 (es) |
IL (1) | IL149495A0 (es) |
IS (1) | IS2841B (es) |
MX (1) | MXPA02004871A (es) |
MY (1) | MY128896A (es) |
NO (1) | NO331215B1 (es) |
NZ (2) | NZ530058A (es) |
PT (1) | PT1237559E (es) |
RU (1) | RU2242232C2 (es) |
SE (1) | SE9904377D0 (es) |
SI (1) | SI1237559T1 (es) |
SK (1) | SK288707B6 (es) |
TW (1) | TWI251491B (es) |
WO (1) | WO2001039781A1 (es) |
ZA (1) | ZA200203707B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7452870B2 (en) | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
US7132408B2 (en) | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
US7115585B2 (en) | 2000-08-21 | 2006-10-03 | Inspire Pharmaceuticals, Inc. | Compositions for treating epithelial and retinal tissue diseases |
US7018985B1 (en) | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
US6897201B2 (en) | 2000-08-21 | 2005-05-24 | Inspire Pharmaceuticals, Inc. | Compositions and methods for the treatment of glaucoma or ocular hypertension |
DE10064797A1 (de) * | 2000-12-22 | 2002-06-27 | Knoll Ag | Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon |
SE0101932D0 (sv) * | 2001-05-31 | 2001-05-31 | Astrazeneca Ab | Pharmaceutical combinations |
US7435724B2 (en) | 2002-02-27 | 2008-10-14 | Inspire Pharmaceutical, Inc. | Degradation-resistant mononucleoside phosphate compounds |
EP1604669A1 (en) * | 2004-06-10 | 2005-12-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of ATP analogues for treatment of cardiovascular diseases |
EP1926736A4 (en) * | 2005-09-21 | 2010-08-25 | Chong Kun Dang Pharm Corp | NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF |
US8759316B2 (en) | 2008-05-13 | 2014-06-24 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
WO2009140092A1 (en) | 2008-05-13 | 2009-11-19 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
US9427448B2 (en) | 2009-11-11 | 2016-08-30 | The Medicines Company | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
US20130303477A1 (en) | 2008-05-13 | 2013-11-14 | The Medicines Company | Maintenance of Platelet Inhibition During Antiplatelet Therapy |
US20120141468A1 (en) | 2008-05-13 | 2012-06-07 | Lisa Ruderman Chen | Maintenance of platelet inhibition during antiplatelet therapy |
US10376532B2 (en) | 2009-11-11 | 2019-08-13 | Chiesi Farmaceutici, S.P.A. | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
PL2498731T3 (pl) * | 2009-11-11 | 2020-07-13 | Chiesi Farmaceutici S.P.A. | Sposoby leczenia lub zapobiegania zakrzepicy w stencie |
AU2012214396B2 (en) | 2011-02-09 | 2017-04-27 | Chiesi Farmaceutici S.P.A. | Methods for treating pulmonary hypertension |
BR112015022070B1 (pt) | 2013-03-09 | 2022-01-18 | Chiesi Farmaceutici S.P.A. | Uso de cangrelor |
US11260071B2 (en) | 2017-06-23 | 2022-03-01 | Chiesi Farmaceutici S.P.A. | Method of preventing of systemic-to-pulmonary-artery shunt thrombosis |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8826448D0 (en) * | 1988-11-11 | 1988-12-14 | Thrombosis Res Inst | Improvements in/relating to organic compounds |
DK0508687T3 (da) * | 1991-04-06 | 1996-02-05 | Astra Pharma Prod | ATP-analoger |
TW326045B (en) * | 1993-02-10 | 1998-02-01 | Astra Pharma Prod | N-alkyl-2-substituted ATP analogues the invention relates to a compound of formula (I) and its pharmaceutically acceptable salt which can be used for inhibition of platelet aggregation. |
MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
SE9404196D0 (sv) * | 1994-12-02 | 1994-12-02 | Astra Ab | New antithrombotic formulation |
CA2226758A1 (en) * | 1995-07-11 | 1997-01-30 | Astra Pharmaceuticals Ltd. | New inhibitors of platelet aggregation |
JP4588877B2 (ja) * | 1998-06-17 | 2010-12-01 | ブリストル−マイヤーズ スクイブ カンパニー | Adp−受容体抗血小板物質と抗高血圧薬の組合せ投与による脳梗塞の予防 |
SE9802973D0 (sv) * | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
TWI229674B (en) * | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
US6462021B1 (en) * | 2000-11-06 | 2002-10-08 | Astrazeneca Ab | Use of low molecular weight thrombin inhibitor |
US6696468B2 (en) * | 2002-05-16 | 2004-02-24 | Dainippon Pharmaceutical Co., Ltd. | (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
AU2003270861A1 (en) * | 2002-10-02 | 2004-04-23 | Bristol-Myers Squibb Company | Novel combination of a factor xa inhibitor and clopidogrel |
US20060160887A1 (en) * | 2003-07-16 | 2006-07-20 | Kyowa Hakko Kogyo Co., Ltd. | Medicinal composition |
-
1999
- 1999-12-01 SE SE9904377A patent/SE9904377D0/xx unknown
-
2000
- 2000-11-21 AR ARP000106143A patent/AR033658A1/es unknown
- 2000-11-29 DE DE60029340T patent/DE60029340T2/de not_active Expired - Lifetime
- 2000-11-29 WO PCT/SE2000/002378 patent/WO2001039781A1/en active IP Right Grant
- 2000-11-29 PT PT00982033T patent/PT1237559E/pt unknown
- 2000-11-29 JP JP2001541513A patent/JP2003515565A/ja not_active Ceased
- 2000-11-29 NZ NZ530058A patent/NZ530058A/en not_active IP Right Cessation
- 2000-11-29 RU RU2002117296/15A patent/RU2242232C2/ru active
- 2000-11-29 DK DK00982033T patent/DK1237559T3/da active
- 2000-11-29 ES ES00982033T patent/ES2267591T3/es not_active Expired - Lifetime
- 2000-11-29 HU HU0203585A patent/HU230890B1/hu unknown
- 2000-11-29 CA CA2391161A patent/CA2391161C/en not_active Expired - Lifetime
- 2000-11-29 MX MXPA02004871A patent/MXPA02004871A/es active IP Right Grant
- 2000-11-29 AT AT00982033T patent/ATE332698T1/de active
- 2000-11-29 NZ NZ518904A patent/NZ518904A/en not_active IP Right Cessation
- 2000-11-29 BR BR0016043-1A patent/BR0016043A/pt not_active Application Discontinuation
- 2000-11-29 US US10/148,526 patent/US20030032618A1/en not_active Abandoned
- 2000-11-29 CN CN00816374A patent/CN1402639A/zh active Pending
- 2000-11-29 CZ CZ20021887A patent/CZ300925B6/cs not_active IP Right Cessation
- 2000-11-29 EP EP06075955A patent/EP1719526A3/en not_active Withdrawn
- 2000-11-29 SI SI200030885T patent/SI1237559T1/sl unknown
- 2000-11-29 SK SK750-2002A patent/SK288707B6/sk not_active IP Right Cessation
- 2000-11-29 IL IL14949500A patent/IL149495A0/xx unknown
- 2000-11-29 KR KR1020027007026A patent/KR100785953B1/ko not_active IP Right Cessation
- 2000-11-29 EE EEP200200271A patent/EE05127B1/xx unknown
- 2000-11-29 CO CO00091389A patent/CO5271717A1/es not_active Application Discontinuation
- 2000-11-29 EP EP00982033A patent/EP1237559B1/en not_active Expired - Lifetime
- 2000-11-29 MY MYPI20005578A patent/MY128896A/en unknown
- 2000-11-29 AU AU19109/01A patent/AU781691B2/en not_active Expired
- 2000-12-05 TW TW089125873A patent/TWI251491B/zh not_active IP Right Cessation
-
2002
- 2002-05-09 ZA ZA200203707A patent/ZA200203707B/xx unknown
- 2002-05-27 IS IS6398A patent/IS2841B/is unknown
- 2002-05-31 NO NO20022606A patent/NO331215B1/no not_active IP Right Cessation
-
2003
- 2003-01-06 HK HK03100127A patent/HK1047893A1/xx not_active IP Right Cessation
-
2006
- 2006-05-25 US US11/441,278 patent/US20060270607A1/en not_active Abandoned
- 2006-09-05 CY CY20061101267T patent/CY1105211T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9904377D0 (sv) | Pharmaceutical combinations | |
DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
CO5611160A2 (es) | Conjugados de agentes terapeuticos o citotoxicos y peptidos biologicamente activos | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
NO20021449D0 (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav | |
DE69826683D1 (de) | Therapeutische zusammensetzungen, enthaltend amlopidin und atorvastatin | |
IT1318649B1 (it) | Composizioni farmaceutiche per il trattamento di mucositi e stomatiti. | |
TR200100054T2 (tr) | Paroksetin metansülfonat | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
DE60134126D1 (de) | 17-alpha-substituierte-11-beta-substituierte-4-aryl und 21-substituierte 19-norpregnadienedione mit antigestagener aktivität | |
PT1224205E (pt) | Derivados 5-beta-sapogenina e pseudo-sapogenina e sua utilizacao no tratamento de demencia | |
BR0208971B1 (pt) | produto absorvente com ajuste melhorado. | |
BR0208970B1 (pt) | produto absorvente com ajuste melhorado. | |
BR0208969B1 (pt) | produto absorvente com ajuste melhorado. | |
NO20005179D0 (no) | Medikament behandling | |
PT1228028E (pt) | Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular | |
SE9802937D0 (sv) | Novel compounds | |
IS7275A (is) | Samsetning fyrir hollegg og notkun á henni | |
BR0012043B1 (pt) | composiÇço de tratamento de cabelo. | |
NO20005548D0 (no) | Mykobakterieinhibitorer | |
DK1011329T3 (da) | 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler | |
NO20021429D0 (no) | 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner | |
ATA17852001A (de) | Signaturarmer und schadstoffreduzierter, pyrotechnischer darstellungskörper | |
DE29811028U1 (de) | Flaschenbehandlungseinrichtung | |
FR2821760B1 (fr) | Le cochonnet aimante |